(Q54103259)

24 May 2018

title

Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. (English)

1 reference

24 May 2018

0 references

J D Spahn

1

1 reference

24 May 2018

D Y Leung

2

1 reference

24 May 2018

M T Chan

3

1 reference

24 May 2018

S J Szefler

4

1 reference

24 May 2018

E W Gelfand

5

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

24 May 2018

The Journal of Allergy and Clinical Immunology

published in

1 reference

24 May 2018

volume

103

1 reference

24 May 2018

issue

3 Pt 1

1 reference

24 May 2018

page(s)

421-426

1 reference

24 May 2018

An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Suppression of Cytokine-Dependent Human T-Cell Proliferation by Intravenous Immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Corticosteroid Action and Resistance in Asthma. Proceedings of a meeting. Buckinghamshire, United Kingdom, October 1995

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

New insights into the pathogenesis and management of steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Glucocorticoid therapy for asthma: clinical pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Steroid Resistance in Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Steroid-resistant asthma: immunologic and pharmacologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Effects of high dose intravenous immunoglobulin in two severe corticosteroid insensitive asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970466-5

7 January 2021

10.1016/S0091-6749(99)70466-5

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018